Start Date: 25/04/2016
End Date: 25/04/2016
Venue: Royal Society of Medicine, London
Royal Society of Medicine
This one day conference will update you on key developments in autosomal dominant polycystic kidney disease (ADPKD) through the review of clinical trials, novel therapies and disease progression tools.
The meeting will look at ADPKD through the perspectives of different specialists, as well as review of the WGIKD summary, the TEMPO 3:4 Trial and who to treat with the Jinarc drug, which was recently recommended by NICE.
The conference will include keynote lectures by Professor Yannick Le Meur from the Universite de Bretagne Occidentale, France, Professor Gerd Walz from the University Medical Centre Freiburg, Germany and Professor Olivier Devuyst from the University of Zurich, Switzerland.
At the end of the meeting, attendees will have a better understanding of:
The clinical overview of ADPKD
How to monitor disease progression
Recent reviews of clinical trials and novel therapies
An overview of management and treatment for ADPKD
The conference is most suitable for nephrologists, paediatricians, geneticists, nurses, members of the multi-disciplinary management team, scientists and patients, however all disciplines are welcome.